Skip to content
Home/Companies/Biotech/Whitelab Genomics
Whitelab Genomics

Whitelab Genomics

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Whitelab Genomics?

Whitelab Genomics is a French Biotech company, currently owned by Omnes Capital since 2022 and Aloe Private Equity.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Omnes Capital
Most recent investor
Omnes Capital
Omnes Real Tech 1 · 2018 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Aloe Private Equity and Omnes Capital since 2020.
Co-invest · 2 holders · 2020 · present
Aloe Private Equity
2020 · present(6yr) · Aloe Environment Fund III · 2014 · Growth
Omnes Capital
2022 · present(4yr) · Omnes Real Tech 1 · 2018 · VC

Questions

Who owns Whitelab Genomics?

Whitelab Genomics is currently owned by Omnes Capital and Aloe Private Equity, through Omnes Real Tech 1, since 2022.

When did Omnes Capital and 1 other acquire Whitelab Genomics?

Omnes Capital and 1 other acquired Whitelab Genomics in 2022.

Who has owned Whitelab Genomics over time?

Whitelab Genomics has been through 2 private-equity ownership periods: Aloe Private Equity · via Aloe Environment Fund III · since 2020; Omnes Capital · via Omnes Real Tech 1 · since 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue